Get the Stockscreener App
6.30
4.65%
0.28
After Hours:
6.38
0.08
+1.27%
Karyopharm Therapeutics Inc Stock (KPTI) Forecast
The Karyopharm Therapeutics Inc (KPTI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.62, representing a +132.08% increase from the current price of $6.30. The highest analyst price target is $17.01, and the lowest is $12.23.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KPTI Price Target
Average 11.16
(+77.19% Upside)
Is Karyopharm Therapeutics Inc (KPTI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 74.15 | Sell |
| STOCH(9,6) | 80.02 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.4247 | Buy |
| ADX(14) | 25.71 | Buy |
| William %R | -6.1544 | Sell |
| CCI(14) | 200.79 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.923
Buy
|
5.2849
Buy
|
| MA20 |
4.5115
Buy
|
4.8258
Buy
|
| MA50 |
4.4533
Buy
|
4.6678
Buy
|
| MA100 |
4.7277
Buy
|
5.2778
Buy
|
| MA200 |
7.3496
Sell
|
7.1338
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, KPTI could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 6 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on KPTI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 74.15 indicates that KPTI is overbought. This suggests that KPTI price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 80.02 indicates that KPTI is oversold. This means that KPTI price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that KPTI is oversold. This suggests that KPTI price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.71 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 200.79 indicates that KPTI is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term KPTI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Karyopharm Therapeutics Inc financial reports and earnings history, Karyopharm Therapeutics Inc (KPTI) stock could reach $2.1317 by 2030, $0.6591 by 2040 and $3.0915 by 2050. See the projected annual prices until 2050 of the Karyopharm Therapeutics Inc stock below:
- Karyopharm Therapeutics Inc (KPTI) is expected to reach an average price of $1.4275 in 2035, with a high prediction of $1.3843 and a low estimate of $1.4492. This indicates an $-77.34% rise from the last recorded price of $6.30.
- Karyopharm Therapeutics Inc (KPTI) stock is projected to chart a bullish course in 2040, with an average price target of $0.6034, representing an $-90.42% surge from its current level. The forecast ranges from a conservative $0.4284 to a sky-high $0.6591.
- Our analysts predict Karyopharm Therapeutics Inc (KPTI) to jump -80.20% by 2045, soaring from $1.4672 to an average price of $1.2472, potentially reaching $1.7505. While $1.4672 is the low estimate, the potential upside is significant.
- Karyopharm Therapeutics Inc (KPTI) stock is expected to climb by 2050, reaching an average of $2.8157, a $-55.31% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.0915 and $0.0931, respectively, highlighting the market's uncertainty.
Karyopharm Therapeutics Inc Stock (KPTI) Year by Year Forecast
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2025
Karyopharm Therapeutics Inc Stock (KPTI) is expected to reach an average price of $18.41 in 2025, with a high prediction of $26.52 and a low estimate of $10.29. This indicates an +192.16% rise from the last recorded price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $12.37 | $12.23 | $17.01 | +96.34% |
| October, 2025 | $12.41 | $10.97 | $12.98 | +96.91% |
| November, 2025 | $11.82 | $11.25 | $13.68 | +87.65% |
| December, 2025 | $12.09 | $11.41 | $14.45 | +91.87% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2026
The predicted value for Karyopharm Therapeutics Inc (KPTI) in 2026 is set at an average of $8.7344. Estimates vary from a peak of $15.37 to a trough of $2.1002, indicating an +38.64% surge from the present price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.44 | $11.09 | $13.76 | +97.53% |
| February, 2026 | $13.83 | $11.68 | $15.34 | +119.54% |
| March, 2026 | $12.32 | $11.98 | $15.37 | +95.52% |
| April, 2026 | $12.53 | $11.82 | $14.80 | +98.95% |
| May, 2026 | $9.5203 | $8.012 | $12.74 | +51.12% |
| June, 2026 | $7.517 | $7.2286 | $9.7195 | +19.32% |
| July, 2026 | $6.7228 | $5.3136 | $8.2161 | +6.71% |
| August, 2026 | $7.8994 | $6.4503 | $8.3094 | +25.39% |
| September, 2026 | $7.6852 | $7.2952 | $8.7869 | +21.99% |
| October, 2026 | $3.1719 | $3.0419 | $7.8531 | -49.65% |
| November, 2026 | $3.4985 | $2.1002 | $3.4985 | -44.47% |
| December, 2026 | $3.5643 | $3.1768 | $4.3143 | -43.42% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Karyopharm Therapeutics Inc (KPTI) is $7.4217, with a high forecast of $12.69 and a low forecast of $2.1583. This indicates an +17.80% increase from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.061 | $2.921 | $3.7868 | -51.41% |
| February, 2027 | $5.3876 | $2.9301 | $6.5085 | -14.48% |
| March, 2027 | $4.0134 | $3.4234 | $5.6368 | -36.29% |
| April, 2027 | $5.9401 | $3.7526 | $6.4801 | -5.71% |
| May, 2027 | $7.6767 | $5.3042 | $7.7267 | +21.85% |
| June, 2027 | $3.8925 | $3.8125 | $12.69 | -38.21% |
| July, 2027 | $5.3892 | $3.8017 | $5.9692 | -14.46% |
| August, 2027 | $4.7758 | $4.7058 | $6.6675 | -24.19% |
| September, 2027 | $4.4816 | $3.0533 | $5.0542 | -28.86% |
| October, 2027 | $2.5783 | $2.1583 | $4.9691 | -59.07% |
| November, 2027 | $3.4249 | $2.5066 | $3.7499 | -45.64% |
| December, 2027 | $3.6307 | $2.2116 | $3.6707 | -42.37% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2028
In 2028, Karyopharm Therapeutics Inc (KPTI) is projected to reach an average price of $2.4122, with a high projection of $4.3373 and a low estimate of $0.4872. This indicates an -61.71% fall from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4974 | $2.9282 | $4.1991 | -44.49% |
| February, 2028 | $3.754 | $2.524 | $4.084 | -40.41% |
| March, 2028 | $3.0998 | $2.6215 | $4.3132 | -50.80% |
| April, 2028 | $3.3165 | $2.679 | $4.3373 | -47.36% |
| May, 2028 | $1.0123 | $0.9173 | $3.819 | -83.93% |
| June, 2028 | $1.8289 | $0.8815 | $2.0806 | -70.97% |
| July, 2028 | $1.7356 | $1.5173 | $2.1264 | -72.45% |
| August, 2028 | $1.5414 | $1.3764 | $2.3348 | -75.53% |
| September, 2028 | $2.678 | $1.5306 | $2.788 | -57.49% |
| October, 2028 | $1.3247 | $1.2153 | $3.4664 | -78.97% |
| November, 2028 | $0.9205 | $0.8105 | $1.4139 | -85.39% |
| December, 2028 | $0.4872 | $0.4872 | $1.1397 | -92.27% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2029
The 2029 price forecast for Karyopharm Therapeutics Inc Stock (KPTI) is $1.0349 on average, with a high prediction of $2.0568 and a low estimate of $0.0129. This represents an -83.57% decrease from the previous price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.543 | $0.1646 | $0.553 | -91.38% |
| February, 2029 | $0.2196 | $0.1346 | $0.6321 | -96.51% |
| March, 2029 | $0.0263 | $0.0337 | $0.2588 | -99.58% |
| April, 2029 | $0.0429 | $0.0129 | $0.2745 | -99.32% |
| May, 2029 | $0.3926 | $0.0979 | $0.2196 | -93.77% |
| June, 2029 | $0.2738 | $0.3147 | $0.2951 | -95.65% |
| July, 2029 | $0.163 | $0.218 | $0.1872 | -97.41% |
| August, 2029 | $0.2317 | $0.2317 | $0.2149 | -96.32% |
| September, 2029 | $0.2945 | $0.1161 | $0.9861 | -95.33% |
| October, 2029 | $0.4903 | $0.1736 | $0.7819 | -92.22% |
| November, 2029 | $0.3069 | $0.1669 | $0.7686 | -95.13% |
| December, 2029 | $2.44 | $0.1661 | $2.0568 | -61.27% |
Karyopharm Therapeutics Inc Stock (KPTI) Price Forecast for 2030
Karyopharm Therapeutics Inc Stock (KPTI) is expected to reach an average price of $11.93 in 2030, with a high forecast of $23.43 and a low forecast of $0.4349. This signifies an +89.41% surge from the last price of $6.30.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1984 | $1.455 | $2.1317 | -80.98% |
| February, 2030 | $1.1149 | $0.4349 | $3.4066 | -82.30% |
| March, 2030 | $1.5182 | $0.8632 | $2.3899 | -75.90% |
| April, 2030 | $1.8815 | $0.7665 | $2.9432 | -70.13% |
| May, 2030 | $2.9881 | $1.3098 | $5.5965 | -52.57% |
| June, 2030 | $4.5764 | $2.2964 | $5.0864 | -27.36% |
| July, 2030 | $9.823 | $4.4347 | $9.963 | +55.92% |
| August, 2030 | $11.87 | $8.6647 | $12.25 | +88.43% |
| September, 2030 | $12.25 | $10.93 | $13.76 | +94.52% |
| October, 2030 | $9.2112 | $8.8062 | $12.79 | +46.21% |
| November, 2030 | $11.56 | $7.1929 | $23.43 | +83.48% |
| December, 2030 | $11.81 | $7.5679 | $16.88 | +87.51% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):